Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis.
Ohashi K, Sato A, Takada T, Arai T, Kasahara Y, Hojo M, Nei T, Nakayama H, Motoi N, Urano S, Eda R, Yokoba M, Tsuchihashi Y, Nasuhara Y, Ishii H, Ebina M, Yamaguchi E, Inoue Y, Nakata K, Tazawa R. Ohashi K, et al. Among authors: nei t. Eur Respir J. 2012 Mar;39(3):777-80. doi: 10.1183/09031936.00076711. Eur Respir J. 2012. PMID: 22379153 Free article. No abstract available.
Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
Ohashi K, Sato A, Takada T, Arai T, Nei T, Kasahara Y, Motoi N, Hojo M, Urano S, Ishii H, Yokoba M, Eda R, Nakayama H, Nasuhara Y, Tsuchihashi Y, Kaneko C, Kanazawa H, Ebina M, Yamaguchi E, Kirchner J, Inoue Y, Nakata K, Tazawa R. Ohashi K, et al. Among authors: nei t. Respir Med. 2012 Feb;106(2):284-93. doi: 10.1016/j.rmed.2011.10.019. Epub 2011 Nov 22. Respir Med. 2012. PMID: 22112784 Free article.
IgM-type GM-CSF autoantibody is etiologically a bystander but associated with IgG-type autoantibody production in autoimmune pulmonary alveolar proteinosis.
Nei T, Urano S, Motoi N, Takizawa J, Kaneko C, Kanazawa H, Tazawa R, Nakagaki K, Akagawa KS, Akasaka K, Ichiwata T, Azuma A, Nakata K. Nei T, et al. Am J Physiol Lung Cell Mol Physiol. 2012 May 1;302(9):L959-64. doi: 10.1152/ajplung.00378.2011. Epub 2012 Feb 24. Am J Physiol Lung Cell Mol Physiol. 2012. PMID: 22367782 Free article.
Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapy.
Tazawa R, Inoue Y, Arai T, Takada T, Kasahara Y, Hojo M, Ohkouchi S, Tsuchihashi Y, Yokoba M, Eda R, Nakayama H, Ishii H, Nei T, Morimoto K, Nasuhara Y, Ebina M, Akira M, Ichiwata T, Tatsumi K, Yamaguchi E, Nakata K. Tazawa R, et al. Among authors: nei t. Chest. 2014 Apr;145(4):729-737. doi: 10.1378/chest.13-0603. Chest. 2014. PMID: 24158247 Clinical Trial.
A Semiquantitative Computed Tomographic Grading System for Evaluating Therapeutic Response in Pulmonary Alveolar Proteinosis.
Tokura S, Akira M, Okuma T, Tazawa R, Arai T, Sugimoto C, Matsumuro A, Hirose M, Takada T, Nakata K, Ishii H, Kasahara Y, Hojo M, Ohkouchi S, Tsuchihashi Y, Yokoba M, Eda R, Nakayama H, Nei T, Morimoto K, Nasuhara Y, Ebina M, Ichiwata T, Tatsumi K, Yamaguchi E, Inoue Y. Tokura S, et al. Among authors: nei t. Ann Am Thorac Soc. 2017 Sep;14(9):1403-1411. doi: 10.1513/AnnalsATS.201607-574OC. Ann Am Thorac Soc. 2017. PMID: 28489417 Clinical Trial.
88 results